West Pharmaceutical
222 hedge funds and large institutions have $2.74B invested in West Pharmaceutical in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 98 increasing their positions, 75 reducing their positions, and 24 closing their positions.
35% more call options, than puts
Call options by funds: $346K | Put options by funds: $257K
31% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 75
1.76% more ownership
Funds ownership: 90.2% → 91.96% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2% less capital invested
Capital invested by funds: $2.81B → $2.74B (-$67.9M)
2% less funds holding
Funds holding: 226 → 222 (-4)
17% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$21.9M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$20.6M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$17.6M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$15.5M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$14.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$35M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$13.1M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$11.9M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$9.99M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$8.81M |
WST Hedge Fund Activity: Q2 2014 in Review
222 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2014, worth a combined $2.74B — down 2.4% from $2.81B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of WST and 20 opened new positions — a net loss of 4 holders — while 75 trimmed existing stakes and 98 added.
The largest buyer was RS Investment Management, adding an estimated $21.9M. The largest seller was Invesco, cutting an estimated $35M.
- 222 institutional investors held West Pharmaceutical (WST) as of Q2 2014, down from 226 in Q1 2014.
- Funds reported $2.74B of West Pharmaceutical stock for Q2 2014, down 2.4% quarter-over-quarter.
- 20 funds opened new West Pharmaceutical positions in Q2 2014 and 24 closed out, a net change of -4 holders.
- The largest West Pharmaceutical buyer in Q2 2014 was RS Investment Management, an estimated $21.9M added.
- The largest West Pharmaceutical seller in Q2 2014 was Invesco, an estimated $35M sold.
Based on aggregated 13F filings for Q2 2014.